Storia della carriera di Jun Axup
Precedenti posizioni note di Jun Axup
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
SOSV Ltd.
 SOSV Ltd. Investment ManagersFinance Sosv Ltd (Sosv) is a multi-stage venture capital and accelerator firm founded in 1994 by Sean O’Sullivan. The firm is headquartered in Ireland with an additional offices in Luxembourg, USA, Hong Kong and China. | Investitore di Private Equity | 01/08/2016 | 01/03/2022 |
Myi Diagnostics & Discovery, Inc.
 Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Direttore operativo | 01/11/2015 | 01/06/2016 |
| Fondatore | 01/11/2015 | 01/06/2016 |
Statistiche
Distribuzione geografica
| Irlanda | 2 |
| Stati Uniti | 2 |
Posizioni
| Private Equity Investor | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Settori
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
SOSV Ltd.
SOSV Ltd. Investment ManagersFinance Sosv Ltd (Sosv) is a multi-stage venture capital and accelerator firm founded in 1994 by Sean O’Sullivan. The firm is headquartered in Ireland with an additional offices in Luxembourg, USA, Hong Kong and China. | Finance |
Myi Diagnostics & Discovery, Inc.
Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Jun Axup
- Esperienza
